EW
Edwards Lifesciences Corporation
Stock
$85.15−0.04 (−0.05%)Close Oct 2, 2026
- Capital expenditures, 2025
- $260M
- YoY, 2025
- +3.1%
- 5-year CAGR
- −8.6%
- 10-year CAGR
- +9.7%
Capital expenditures
Capital expenditures by fiscal year
| Period | Capex | YoY |
|---|---|---|
| 2025 | $260M | +3.1% |
| 2024 | $252M | −0.2% |
| 2023 | $253M | +3.4% |
| 2022 | $245M | −24.9% |
| 2021 | $326M | −20.0% |
| 2020 | $407M | +60.0% |
| 2019 | $254M | +6.6% |
| 2018 | $239M | +42.0% |
| 2017 | $168M | −4.5% |
| 2016 | $176M | +71.5% |
| 2015 | $103M | +23.9% |
| 2014 | $83M | −23.9% |
| 2013 | $109M | 0.0% |
| 2012 | $109M | +42.3% |
| 2011 | $77M | +23.9% |
| 2010 | $62M | −3.4% |
| 2009 | $64M | +26.5% |
| 2008 | $51M | — |